Researchers at RIT are developing non-invasive technology that will better assess cardiac tissue response to thermal energy, a common therapy approach for both cancer and cardiac arrhythmia treatments ...
Dr Michele Orini shares how machine learning can help identify critical VT ablation targets for a safer, data-driven ...
BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one ...
Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...
Atrial fibrillation (AF) remains the most common sustained cardiac arrhythmia, posing significant public health challenges due to its association with stroke, heart failure and diminished quality of ...
HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) ...
Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor's Vision-MR TM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance ...
Dr. Steven Mickelsen dreamed up a new way to treat a heart condition called atrial fibrillation while finishing a medical fellowship at the University of Iowa in 2012. His idea of using pulsed ...
SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a pioneer in arrhythmia care and developer of vMap®, the world’s first technology to accurately map arrhythmias using the patient’s 12-lead ECG data, ...
More people have atrial fibrillation (AFib) than any other kind of irregular heartbeat. And the numbers are only expected to go up as people live longer with heart conditions that go along with it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback